MONOTHERAPY CHOICES IN EARLY PARKINSON'S DISEASE

罗哌尼罗 医学 帕金森病 左旋多巴 内科学 普拉克索 中止 多巴胺能 运动症状 运动障碍 疾病 物理疗法 多巴胺
作者
Rebecca Morrison,E. J. Newman,Donald G. Grosset
出处
期刊:Journal of Neurology, Neurosurgery, and Psychiatry [BMJ]
卷期号:84 (11): e2.73-e2
标识
DOI:10.1136/jnnp-2013-306573.164
摘要

Background

Motor symptoms in Parkinson9s disease (PD) include tremor, bradykinesia, rigidity and postural instability. Initial monotherapy choices in early Parkinson9s disease (PD) include L–dopa, dopamine agonists and MAO–B inhibitors. We reviewed the dopaminergic medication prescribed in drug–naïve early PD patients in routine clinical practice, and compared the change in motor symptoms post drug commencement using MDS–UPDRS III.

Methods

Patients commenced on monotherapy for PD within a regional movement disorder service between 2009 and 2011 were retrospectively identified. MDS–UPDRS III scores were compared at baseline with clinical assessment following drug commencement. Patients were excluded from analysis if the antiparkinson medication was discontinued or a second agent was added.

Results

Data were available for 29 patients (66% male) meeting inclusion criteria. All patients had either been commenced on L–dopa (n=15, 80% male) or ropinirole (n=14, 50% male). L–dopa patients were older (mean 70.8 years (standard deviation 6.2) vs 61.6 years (10.6), p=0.011). The mean daily L–dopa dose used was 233.3 mg (74.8) and the mean daily ropinirole dose was 4.57 mg (1.45). The baseline MDS–UPDRS III was higher in the L–dopa group (28.3 (15.3) vs 18.8 (7.6), p=0.045), indicating worse motor impairment. There was no difference in the timing of repeat clinical assessment post–commencement of antiparkinson medication (230 days (106) vs 214 days (126), p=0.715). The improvement in MDS–UPDRS III following drug commencement was not significantly greater in the L–dopa group (–4.47 (11.0) vs +0.21 (6.8), p=0.178). However, following introduction of medication there was no difference in MDS–UPDRS III scores between groups (23.8 (11.8) vs 19.0 (8.7), p=0.213).

Conclusions

This suggests that age and motor severity were the main drivers in choosing which agent to commence as monotherapy in early PD, with L–dopa prescribed more frequently for older patients and those with greater motor symptoms.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
小伟完成签到,获得积分10
3秒前
王吉萍完成签到 ,获得积分10
10秒前
yangy801017完成签到 ,获得积分10
11秒前
青青河边草完成签到,获得积分10
12秒前
Lorry完成签到 ,获得积分10
12秒前
对先生完成签到 ,获得积分10
14秒前
U2完成签到,获得积分10
15秒前
北月南弦完成签到 ,获得积分10
17秒前
Kitty完成签到,获得积分10
17秒前
EvianLee完成签到 ,获得积分10
17秒前
涛老三完成签到 ,获得积分10
17秒前
整齐盼烟完成签到,获得积分10
19秒前
花样年华完成签到,获得积分10
20秒前
亚男66完成签到,获得积分10
22秒前
AKira完成签到 ,获得积分10
24秒前
科研一坤年完成签到,获得积分10
27秒前
cmaz完成签到 ,获得积分10
28秒前
28秒前
lily完成签到 ,获得积分10
29秒前
幽默的迎天完成签到,获得积分10
32秒前
32秒前
33秒前
顺利的夜白完成签到 ,获得积分10
36秒前
淡淡完成签到 ,获得积分10
40秒前
四川第一深情完成签到 ,获得积分10
40秒前
太少拿米完成签到,获得积分10
43秒前
parantal发布了新的文献求助30
47秒前
syvshc的应助被parantal采纳,获得10
47秒前
YQ完成签到 ,获得积分10
48秒前
乐观怜寒完成签到,获得积分10
48秒前
彭于晏的应助被xiaowang采纳,获得10
48秒前
辛勤的冰珍完成签到,获得积分10
50秒前
ZylaFaye完成签到 ,获得积分10
50秒前
wjw完成签到,获得积分10
52秒前
马艺涵完成签到 ,获得积分10
53秒前
AHMZI完成签到,获得积分10
53秒前
尊敬的芷卉完成签到,获得积分10
54秒前
幽默的听寒完成签到 ,获得积分10
55秒前
57秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173347
求助须知:如何正确求助?哪些是违规求助? 9565632
关于积分的说明 21780648
捐赠科研通 7767505
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555841
邀请新用户注册赠送积分活动 2476749